Two Sigma Investments’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.2M Sell
177,901
-63,312
-26% -$1.27M ﹤0.01% 2390
2025
Q4
$5.65M Sell
241,213
-144,990
-38% -$3.15M 0.01% 1601
2025
Q3
$7.7M Buy
386,203
+196,791
+104% +$3.53M 0.01% 1116
2025
Q2
$2.59M Buy
189,412
+172,124
+996% +$1.65M ﹤0.01% 1651
2025
Q1
$191K Sell
17,288
-39,607
-70% -$422K ﹤0.01% 2862
2024
Q4
$606K Sell
56,895
-30,139
-35% -$361K ﹤0.01% 2446
2024
Q3
$1.11M Sell
87,034
-13,388
-13% -$199K ﹤0.01% 2065
2024
Q2
$1.69M Buy
100,422
+19,925
+25% +$283K ﹤0.01% 1660
2024
Q1
$1.21M Sell
80,497
-50,258
-38% -$821K ﹤0.01% 1834
2023
Q4
$1.96M Buy
130,755
+10,541
+9% +$137K ﹤0.01% 1567
2023
Q3
$1.68M Buy
120,214
+100,399
+507% +$1.61M ﹤0.01% 1531
2023
Q2
$205K Buy
+19,815
New +$219K ﹤0.01% 2636
2021
Q2
Sell
-19,800
Closed -$386K 4758
2021
Q1
$386K Buy
+19,800
New +$420K ﹤0.01% 3152
2018
Q4
Sell
-5,954
Closed -$281K 3660
2018
Q3
$281K Sell
5,954
-9,022
-60% -$419K ﹤0.01% 2811
2018
Q2
$745K Buy
+14,976
New +$872K ﹤0.01% 2362
2018
Q1
Sell
-7,436
Closed -$277K 3642
2017
Q4
$277K Buy
+7,436
New +$265K ﹤0.01% 2766

Other funds holding URGN